Home
About Us
Services
Markets
Resarch
Online Trading
Back Office
Contact Us
Download
Equities
Top Gainers & Losers
Advances & Declines
New Highs & Lows
Value Toppers
Volume Toppers
52 Week High & Low
News Analysis
Pre-Session
Mid-Session
End-Session
Market Beat
Hot Pursuit
Stock Alert
Economy News
Corporate News
Foreign Markets
Corporate Results
Other Markets
Corporate Action
BSE Announcements
NSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Change Of Names
Split Of Face Value
Other Markets
ADR Prices
GDR Prices
World Indices
Forex Details
Company Profile
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit And Loss
Quarterly Results
Financial Ratios
Share Price
Technical Chart
Mutual Fund
Fund Profile
Fund Performance
Fund Ranking
Scheme Profile
Daily NAV
MF Synopsis
Historical NAV
Dividend Details
MF News
MF Activity
Top 10 Holdings
New Fund Offer
Returns Calculator
SIP Calculator
IPO
Forthcoming Issues
Open Issues
Closed Issues
New Listing
Basis Of Allotment
Draft Prospectus
New Issue Monitor
BACK
Your are on :
Markets |
IPO
|
IPO Synopsis
As on: Mar 28,2024 06:14 PM
Earum Pharmaceuticals Ltd
Registered Office:
G1 Ground Floor VR Complex,Nr Sanathal Cross Rd SP RingRd, Ahmedabad - 382210, Gujarat, India.
Phone : 91-79-48402525 Fax:
Email :
cs@earumpharma.com
Website :
www.earumpharma.com
Initial Public Offer of 18,48,000 equity shares of face value of Rs.10 each (the "equity shares") of Earum Pharmaceuticals Limited ("the company" or "epl" or "the issuer") at an issue price of Rs.36 per equity share for cash, aggregating up to Rs. 6.65 Crores ("public issue") out of which 96,000 equity shares of face value of Rs. 10 each, at an issue price of Rs. 36 per equity share for cash, aggregating Rs. 0.35 Crores will be reserved for subscription by the market maker to the issue (the "market maker reservation portion"). the public issue less market maker reservation portion i.e. issue of 17,52,000 equity shares of face value of Rs. 10 each, at an issue price of Rs. 36 per equity share for cash, aggregating upto Rs. 6.31 Crores is here in after referred to as the "net issue". the public issue and net issue will constitute 29.96% and 28.41 % respectively of the post issue paid-up equity share capital of the company. The face value of the equity share is Rs.10 each. Fixed Price issue at Rs.36 per share and is 3.6 times of the face value.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
21-Jun-19
26-Jun-19
36.00-0.00
0.00-0.00
Minimum Application for shares in Nos : 3000 Further Multiples of : 3000
(
R
s
)
Lead Managers to the Issue
Project Cost
6.65
Hem Securities Ltd
Project Financed through Current Offer
6.65
Post Issue Equity Share Capital
6.17
Issue Price
36.00
Projects
To Meet Working Capital Requirements
General Corporate Purpose
Promoted By
Bhumishth Narendrabhai Patel
Payal Bhumishth Patel
Listing At
BSE - SME
Registrar to the Issue
No Data Available
Product
Disclaimer
Mandatory Information
Privacy Policy
Careers
Risk disclosures
Feedback
Scores
Investor Charter
STOCK BROKER
DEPOSITORY PARTICIPANTS
INVESTOR GRIEVANCES ESCALATION MATRIX
Member Bank Details
"Investor Grievance"
Mail your Grievance to
info@lalkar.in
Important Links:
SEBI
|
NSE
|
BSE
|
MCX-SX
|
MCX
|
NCDEX
|
NSDL
|
CDSL
|
FMC
|
CDSL E-Voting
|
SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434 | BSE FNO: INZ000269434 | NSE CASH: INZ000269434 | NSE FNO: INZ000269434 | NSE CD: INZ000269434 | MSEI CASH: INZ000269434 | MSEI FNO: INZ000269434 | MSEI CD: INZ000269434
AMFI NO : ARN- 19226 | LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved
Designed, developed & powered by
CMOTS Infotech
(ISO 9001:2015 certified)